The trademark OxyNal was filed by PB Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on September 22, 2016, and received one opposition filed on December 22, 2016 by Novartis AG on Likelihood of confusion. the opponent was represented by BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBB - PATENTANWÄLTE RECHTSANWÄLTE and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 22, 2016
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).